Newly prequalified Active Pharmaceutical Ingredients (APIs)
M
Linezolid (WHOAPI-252) and Kanamycin (acid
First liposomal amphotericin B powder for injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Second rectal artesunate capsule prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Ipca's paediatric artemether/lumefantrine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Labesfal's Mg injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Hisun's kanamycin injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
MSN's moxifloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
ViiV Healthcare's abacavir/lamivudine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list: